RZLT Rezolute, Inc.

NASDAQ
$3.88

Rezolute, Inc. (RZLT) is expected to report earnings on February 4, 2027, after the market close. The consensus earnings estimate is a loss of $0.16 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +5.7% since its last earnings release on November 5, 2026.

Rezolute Reported In-line with Estimates
Thursday, November 5, 2026 · 4:05 PM ET
Earnings Date
2nd Quarter, Dec 2026
Feb 4
Thursday · 4:05 PM ET
Earnings Whisper
-
vs ($0.16)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $4.13

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Rezolute, Inc.

Rezolute strives to disrupt current treatment paradigms by developing transformative therapies for devastating rare and chronic metabolic diseases.

Sector

Healthcare

Industry

Biotechnology

Held By 1 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.